| GOLDMAN SACHS US TECHNOLOGY OPPORTUNITIES EQUITY PORTFOLIO P USD CAP | RVI TECNOLOGÍA | 21,635220 | 29/10/2026 | 26,41% | 114,74% | *** |
| BESTINVER BOLSA, FI | RV ESPAÑA | 142,654789 | 29/10/2026 | 10,34% | 114,71% | *** |
| AXA IM JAPAN EQUITY B EUR HEDGED ACC | RVI JAPÓN | 30,620000 | 29/10/2026 | 25,24% | 114,58% | ***** |
| POLAR CAPITAL JAPAN VALUE S USD DIS HEDGED | RVI JAPÓN VALOR | 10,089847 | 29/10/2026 | 32,98% | 114,48% | **** |
| POLAR CAPITAL JAPAN VALUE S EUR DIS HEDGED | RVI JAPÓN VALOR | 7,067400 | 29/10/2026 | 24,26% | 114,42% | ***** |
| FONDITEL LINCE, FI B | RV ESPAÑA | 15,677765 | 28/10/2026 | 12,81% | 114,39% | *** |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 USD | RVI BIOTECNOLOGÍA | 36,666667 | 29/10/2026 | 16,88% | 114,37% | **** |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND I GBP HEDGED | RVI JAPÓN VALOR | 473,379717 | 29/10/2026 | 16,11% | 114,28% | **** |
| POLAR CAPITAL JAPAN VALUE I USD DIS HEDGED | RVI JAPÓN VALOR | 29,815094 | 29/10/2026 | 33,08% | 114,28% | **** |
| GENERALI INVESTMENTS SICAV - CENTRAL & EASTERN EUROPEAN EQUITY EX | RVI EMERGENTES EUROPA | 475,068000 | 28/10/2026 | 24,97% | 114,25% | **** |
